CapLaw-2020-35

On 20 May 2020, Idorsia Ltd, a Swiss biopharmaceutical company, successfully completed a private placement with institutional investors of 11 million new registered shares, corresponding to 8.4% of its currently issued share capital, by way of an accelerated bookbuilding process. The shares were placed at CHF 30.00 per share, resulting in gross proceeds of CHF…